These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16098052)

  • 1. Role of apaf-1 in melanoma drug resistance and apoptosis.
    Röckmann H; Schadendorf D
    J Invest Dermatol; 2005 Aug; 125(2):386-7. PubMed ID: 16098052
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance.
    Campioni M; Santini D; Tonini G; Murace R; Dragonetti E; Spugnini EP; Baldi A
    Exp Dermatol; 2005 Nov; 14(11):811-8. PubMed ID: 16232302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis and melanoma chemoresistance.
    Soengas MS; Lowe SW
    Oncogene; 2003 May; 22(20):3138-51. PubMed ID: 12789290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma resistance gene identified.
    Bond T
    Biomark Med; 2013 Apr; 7(2):199. PubMed ID: 23667941
    [No Abstract]   [Full Text] [Related]  

  • 5. APAF-1 signaling in human melanoma.
    Anichini A; Mortarini R; Sensi M; Zanon M
    Cancer Lett; 2006 Jul; 238(2):168-79. PubMed ID: 16095810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents.
    Zanon M; Piris A; Bersani I; Vegetti C; Molla A; Scarito A; Anichini A
    Cancer Res; 2004 Oct; 64(20):7386-94. PubMed ID: 15492260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No longer a molecular black box--new clues to apoptosis and drug resistance in melanoma.
    Satyamoorthy K; Bogenrieder T; Herlyn M
    Trends Mol Med; 2001 May; 7(5):191-4. PubMed ID: 11325619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of terminal differentiation in melanoma cells on downregulation of beta-amyloid precursor protein.
    Botelho MG; Wang X; Arndt-Jovin DJ; Becker D; Jovin TM
    J Invest Dermatol; 2010 May; 130(5):1400-10. PubMed ID: 19759550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of APAF-1 expression in human cutaneous melanoma progression.
    Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
    Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma stem cells.
    Roesch A
    J Dtsch Dermatol Ges; 2015 Feb; 13(2):118-24. PubMed ID: 25631128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma never says die.
    Haass NK; Schumacher U
    Exp Dermatol; 2014 Jul; 23(7):471-2. PubMed ID: 24684560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond ABC: another mechanism of drug resistance in melanoma side population.
    Fukunaga-Kalabis M; Herlyn M
    J Invest Dermatol; 2012 Oct; 132(10):2317-2319. PubMed ID: 22971921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Living and letting die--new mechanisms of apoptosis resistance in melanoma cells]].
    Hautarzt; 2001 Apr; 52(4):386-7. PubMed ID: 11382133
    [No Abstract]   [Full Text] [Related]  

  • 14. Apoptosis and melanoma: how new insights are effecting the development of new therapies for melanoma.
    Hersey P
    Curr Opin Oncol; 2006 Mar; 18(2):189-96. PubMed ID: 16462190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance in human melanoma: mechanisms and therapeutic opportunities.
    Röckmann H; Schadendorf D
    Onkologie; 2003 Dec; 26(6):581-7. PubMed ID: 14709935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective apoptosis underlies chemoresistance in ovarian cancer.
    Hajra KM; Tan L; Liu JR
    Adv Exp Med Biol; 2008; 622():197-208. PubMed ID: 18546629
    [No Abstract]   [Full Text] [Related]  

  • 17. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
    Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E
    Cancer Res; 2001 Dec; 61(23):8395-400. PubMed ID: 11731416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma biology and new targeted therapy.
    Gray-Schopfer V; Wellbrock C; Marais R
    Nature; 2007 Feb; 445(7130):851-7. PubMed ID: 17314971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics displays cytoskeletal proteins and chaperones involvement in Hedyotis corymbosa-induced photokilling in skin cancer cells.
    You BJ; Wu YC; Wu CY; Bao BY; Chen MY; Chang YH; Lee HZ
    Exp Dermatol; 2011 Aug; 20(8):653-8. PubMed ID: 21569101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of apoptotic protease activating factor-1 expression and resistance to hypoxia-induced apoptosis in cervical cancer.
    Leo C; Horn LC; Rauscher C; Hentschel B; Richter CE; Schütz A; Leo CP; Höckel M
    Clin Cancer Res; 2007 Feb; 13(4):1149-53. PubMed ID: 17317823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.